Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financials
CVKD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 5.6 million | 1.5 million |
| March 31, 2026 | 2.9 million | 1.1 million |
| Dec. 31, 2025 | 4.3 million | 1.6 million |
| Sept. 30, 2025 | 4.1 million | 1.4 million |
CVKD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.2 million | 672102 |
| March 31, 2026 | -3.0 million | 252364 |
| Dec. 31, 2025 | -2.6 million | 325103 |
| Sept. 30, 2025 | -2.4 million | 473384 |
CVKD Net Income
No data available :(
CVKD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.4 million | - | - |
| March 31, 2026 | 2.3 million | - | - |
| Dec. 31, 2025 | 4.0 million | - | - |
| Sept. 30, 2025 | 3.9 million | - | - |
CVKD Shares Outstanding
CVKD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 705151 | 2.6 million | - |
| March 31, 2026 | 3 | 771508 | 1.7 million | - |
| Dec. 31, 2025 | 3255 | 666323 | 2.4 million | - |
| Sept. 30, 2025 | 1853 | 688465 | 2.0 million | - |
CVKD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 555 |
| Dec. 31, 2025 | - | 555 |
| Sept. 30, 2025 | - | 401 |
CVKD
Price: $1.58
52 week price:
Earnings Per Share: -4.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.8 million